Form D · Pharmaceuticals
BIO BLAST PHARMA LTD.
New Haven, CT · CIK 0001596812
Offering snapshot reported Apr 1, 2016 · SEC filing
- Reported sold
- $6.7M Offering amount: $6.7M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 22, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 1, 2016 | Initial | $6,699,999 | No comparison | 4 | SEC filing |
| Feb 13, 2014 | Initial | $4,750,000 | No comparison | 28 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $469K
- Finders' fees
- $0
- Form D file number
- 021-260527
The warrants were issued in connection with an offering of (i) approximately 2.16 million ordinary shares issued in a registered direct offering, and (ii) unregistered warrants to purchase approximately 1.08 ordinary shares.
The brokers are also entitled to an aggregate expense reimbursement of $35,000.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Roth Capital Partners, LLC | 15407 | |
| H.C. Wainwright & Co., LLC | 375 |
Source: Form D, filed Apr 1, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Burshtine | Director |
| Leigh Cherry | Executive |
| Gili Cohen | Director |
| Robert Cook | Executive |
| Yaron Daniely | Director |
| Thomas I. H. Dubin | Director |
| Paul Firuta | Executive |
| Colin Foster | Director, Executive |
| Udi Gilboa | Director |
| Marlene Haffner | Director |
| Isaac Krymolowski | Director |
| Dalia Megiddo | Director |
| Ran Nusbaum | Director |
| Fredric Price | Director, Executive |
| Theresa M. Stevens | Executive |
| Warren Wasiewski | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
Connecticut Financial Center 157 Church Street (19 Th Floor)
New Haven, CT, 06510
New Haven, CT, 06510